Use of trastuzumab for metastatic breast cancer in Australia: inaccurate results and alternative interpretation of findings

J Clin Oncol. 2007 Dec 10;25(35):5662-3; author reply 5663-4. doi: 10.1200/JCO.2007.14.2182.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Antibodies, Monoclonal / economics
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Australia
  • Breast Neoplasms / drug therapy*
  • Drug Costs
  • Female
  • Humans
  • Middle Aged
  • Monitoring, Physiologic
  • Neoplasm Metastasis / drug therapy
  • Trastuzumab
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Trastuzumab